JP Morgan Maintains Overweight on MetLife, Raises Price Target to $108

Benzinga Newsdesk www.benzinga.com Positive 74.6%

Neg 0% Neu 0% Pos 74.6%

JP Morgan analyst Pablo Singzon maintains MetLife (NYSE:MET) with a Overweight and raises the price target from $106 to $108.